Status:
COMPLETED
VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program
Lead Sponsor:
Nordsjaellands Hospital
Collaborating Sponsors:
Bispebjerg Hospital
Herlev and Gentofte Hospital
Conditions:
Deep Vein Thrombosis, Pulmonary Embolus
Colon Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Based on data on a cohort of 2,141 patients undergoing elective colonic cancer resection in an ERAS program, the incidence of postoperative thromboembolic events is estimated in patients no receiving ...
Detailed Description
The Copenhagen cOmplete Mesocolic Excision Study (COMES) database contains comprehensive data on preoperative, intraoperative, postoperative and tumor related variable on patients undergoing elective ...
Eligibility Criteria
Inclusion
- elective macroradical resection for UICC Stage I-III colonic adenocarcinoma
Exclusion
- concomitant rectum resection
- soly appendix carcinoma
- diagnosed with pulmonary embolism or deep venous thrombosis before primary discharge
- dying before discharge from the hospital or discharged at postoperative day 28 or later
- treatment with vitamin K antagonists, heparin or new oral anticoagulants before or after surgery
- VTE less than 3 months before the colon resection
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2018
Estimated Enrollment :
2141 Patients enrolled
Trial Details
Trial ID
NCT06009484
Start Date
January 1 2014
End Date
March 15 2018
Last Update
August 24 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.